Deltamycins, new macrolide antibiotics. I. Producing organism and fermentation. 1978

Y Shimauchi, and K Okamura, and A Koki, and M Hasegawa, and M Date, and Y Fukagawa, and K Kouno, and T Ishikura

A streptomycete strain, P3409, which produced new basic macrolide antibiotics, deltamycins A1, A2 and A3 and carbomycin A (deltamycin A4) was considered to be a new subspecies for which the name Streptomyces halstedii subsp. deltae was proposed. Deltamycins A1, A2, A3 and A4 which were active against Gram-positive bacteria were produced in organic complex media.

UI MeSH Term Description Entries
D007933 Leucomycins An antibiotic complex produced by Streptomyces kitasatoensis. The complex consists of a mixture of at least eight biologically active components, A1 and A3 to A9. Leucomycins have both antibacterial and antimycoplasmal activities.
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D005285 Fermentation Anaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID. Fermentations
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D013302 Streptomyces A genus of bacteria that form a nonfragmented aerial mycelium. Many species have been identified with some being pathogenic. This genus is responsible for producing a majority of the ANTI-BACTERIAL AGENTS of practical value.

Related Publications

Y Shimauchi, and K Okamura, and A Koki, and M Hasegawa, and M Date, and Y Fukagawa, and K Kouno, and T Ishikura
December 1980, The Journal of antibiotics,
Y Shimauchi, and K Okamura, and A Koki, and M Hasegawa, and M Date, and Y Fukagawa, and K Kouno, and T Ishikura
October 1983, The Journal of antibiotics,
Y Shimauchi, and K Okamura, and A Koki, and M Hasegawa, and M Date, and Y Fukagawa, and K Kouno, and T Ishikura
February 1980, The Journal of antibiotics,
Y Shimauchi, and K Okamura, and A Koki, and M Hasegawa, and M Date, and Y Fukagawa, and K Kouno, and T Ishikura
September 1978, The Journal of antibiotics,
Y Shimauchi, and K Okamura, and A Koki, and M Hasegawa, and M Date, and Y Fukagawa, and K Kouno, and T Ishikura
November 1986, The Journal of antibiotics,
Y Shimauchi, and K Okamura, and A Koki, and M Hasegawa, and M Date, and Y Fukagawa, and K Kouno, and T Ishikura
October 1987, The Journal of antibiotics,
Y Shimauchi, and K Okamura, and A Koki, and M Hasegawa, and M Date, and Y Fukagawa, and K Kouno, and T Ishikura
September 1980, The Journal of antibiotics,
Y Shimauchi, and K Okamura, and A Koki, and M Hasegawa, and M Date, and Y Fukagawa, and K Kouno, and T Ishikura
December 1981, The Journal of antibiotics,
Y Shimauchi, and K Okamura, and A Koki, and M Hasegawa, and M Date, and Y Fukagawa, and K Kouno, and T Ishikura
April 1983, The Journal of antibiotics,
Y Shimauchi, and K Okamura, and A Koki, and M Hasegawa, and M Date, and Y Fukagawa, and K Kouno, and T Ishikura
May 1978, The Journal of antibiotics,
Copied contents to your clipboard!